Author

Daniel M. Corey

ORCID 0009-0006-4347-4646Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Daniel M. Corey1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

Abhishek MaitiiD· 1 shared Alexander ArballoiD· 1 shared Ankit BhattaiD· 1 shared Bi YuiD· 1 shared Brandon CieniewicziD· 1 shared Damoun TorabiiD· 1 shared Edson OliveiraiD· 1 shared Hongxiu NingiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abhishek MaitiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyClinical Cancer ResearchPeer-reviewedMar 7, 2024

Therapeutic Targeting of TIM-4-L With Engineered T Cells for Acute Myeloid Leukemia

Brandon Cieniewicz, Edson Oliveira, Mike Saxton…·Daniel M. Corey

This study identifies TIM-4-L as a novel target for T cell therapy in AML, showing engineered T cells effectively eliminate AML cells in vitro and in vivo.

3 citations

humanflow cytometry

𝕏 PostBluesky